AtriCure (ATRC) stock
ATRC's Quality Score fell 1 point on Fri, Oct 30, to 17. Buying volume slipped off its 20-day high.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on ATRC
| The company | Sales up 62% |
| Latest filing | 10-Q, Jul 27 |
ATRC in the news
ReportReports tomorrow, after the close. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -1.1% on average. Past reports ›
What's next
Mon Nov 9: UBS Global Healthcare Conference 2026Investor conference · date confirmed.
1 more date ahead: the conference, for Pro members.
ATRC catalysts
After its last 4 reports it closed -1.1% on average, higher 1 of 4 times.
Why ATRC scores 17
Excellentfor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
- +6Chart checks 6 of 14 firing right now, one point each
- +3Long-term trend above a rising 200-day average, near its 52-week high
- Run-up adds
- Profit adds
- Growth adds
- Persistence adds
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
ATRC has 6 of 14 chart checks firing
ATRC RSI today: 57.2, above its 50-day and 200-day averages
- RSI 1457.2
- MACD (12, 26, 9)Above signal
- 50-day average$55.80
- 200-day average$38.18
- 50/200 crossGolden cross
- ADX 1431.6
- Support$55.16
- Resistance$61.70
- 52-week high$63.00
- 52-week low$25.36
- Chart patternRising channel
- Bollinger Bands (20, 2)Inside
- Volume1.6x
The deep dive on ATRC
- What it does and how it makes money
- Where it stands
- What changed in its filingsSEC filing · Feb 19, 2026, against the one of Feb 14, 2025
- Who holds and trades it
- Against its closest peers
How ATRC ranks in Medical Devices
ATRC is #2 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score |
Sales over four quarters against a year before: ATRC +14%, INSP +4.3%, GMED +20%, MMSI +10%.
When does ATRC report earnings, and what happens after?
Reports Tue Nov 3, after the close (tomorrow). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What ATRC reported on Jul 23, 2026
The quarter
The figures are not read from the release yet.
“U.S. revenue growth was driven by sales of our cryoSPHERE ® MAX ™ probe for post-operative pain management, EnCompass ® clamp in open ablation, and AtriClip FLEX-Mini ® and AtriClip PRO-Mini ® devices for appendage management.”
Where the sales came from
ATRC's results filing gives no sales by line in a table we read.
The outlook
| Measure | Figure |
|---|---|
| Revenue | $602M to $610M |
In the company's words
“Gross margin was 77.2% for the second quarter 2026, an increase of 269 basis points from the second quarter 2025, driven primarily by favorable product and geographic mix, along with manufacturing efficiencies.”
From its results filing (SEC filing · Jul 23)
The numbers
- $3.2B
- today
- $570M
- up 13.9% on the year
- $53.1M
- last 12 months
Sales grew 21% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 2.5% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Jul 23, 2026 | +2.1% | +6.2% | +21.7% |
| May 5, 2026 | -4.2% | -4.7% | -9.2% |
| Feb 17, 2026 | +0.1% | -2.1% | -5.5% |
ATRC sales and profit by year
Sales grew in six of the last seven years, to $535M in 2025. It made a profit in one of the eight years.
Insiders trading ATRC
ATRC insider trades
7 insiders sold $2.7M across 9 filings in the last 6 months. No open-market buys on record. The newest:
ATRC trades by Congress and the executive branch
2 trades disclosed in the last six months. The newest:
ATRC's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold ATRC?
In ETFs: ATRC is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About AtriCure
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
What AtriCure says it competes with
“However, our industry is competitive, is subject to change and can be significantly affected by new product introductions and other activities of industry participants.”
ATRC's score card
Pro members see every line of every stock's score.
- What would move ATRC's score: 3 things
- 1 more filing explained, a plain line each
- Real-time prices, no delay
Straight Answers
Is ATRC a good stock to buy? What its Quality Score says
ATRC scores 17 today, which Breakaway calls Excellent. It is #2 of 85 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is ATRC's Quality Score?
ATRC scores 17 today, which Breakaway calls Excellent (15 to 19). That is #2 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ATRC's 17.
Are insiders buying ATRC?
7 insiders sold $2.7M across 9 filings in the last 6 months. No open-market buys on record. The newest is Regina E. Groves, Director, who sold $288K on Sep 11. Every filing, with the scored weight, for Pro members.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.